EDN1 and myocardial ischemia: Evidence has been accumulated that YXS is an effective treatment in the intervention of various cardiovascular diseases including myocardial ischemia/reperfusion injury, H2O2-caused damage, and ET-1-induced cardiomyocyte dysfunction [6, 13, 14].